|
Study ID | Sample | Diagnosis standard | Intervention | Control | Course (week) | Outcome measure |
|
Ke et al. (2012) [44] | 65 | CGMH-2005; RTOAPR-2002; TCM diagnostic criteria (unclear) | Modified Fuling Guizhi Baizhu Gancao decoction (1 dose/d) + control | Proper diet + exercise | 4 | BP |
Quan and Lei (2011) [45] | 40 | CGMH-2005; AASIOSWG-2000; TCM diagnostic criteria (unclear) | Modified Liujunzi decoction (1 dose/d) + control | Benazepril (10 mg qd) | 8 | BP |
Lian (2012) [46] | 90 | CGMH-2010; PCGOOCA-2003; GCRNDTCM | Modified Wendan decoction (400 mL/d) + control | Benzenesulfonic levamlodipine (5 mg qd) | 4 | BP |
Wang et al. (2006) [47] | 60 | 1999 WHO-ISH GMH; AASIOSWG-2000; TCM diagnostic criteria (unclear) | Pinggan Yishen Ditan decoction (1 dose/d) + control | Benazepril hydrochloride (10 mg qd) | 8 | BP |
Hu et al. (2011) [48] | 120 | 1999 WHO-ISH GMH; AASIOSWG-2000; TCM diagnostic criteria (unclear) | Naoxintong capsule (0.8 g tid) + control | Amlodipine (2.5 mg qd) | 12 | BP |
Gao (2007) [49] | 60 | 1999 WHO-ISH GMH; diagnostic criteria for obesity (unclear); GCRNDTCM | Decoction of calming liver, expelling phlegm and removing blood stasis (1 dose/d) + control | Nitrendipine (10 mg tid) | 4 | BP |
Zhang et al. (2003) [50] | 34 | 1979 WHO GMH; diagnostic criteria for obesity (unclear); TCM diagnostic criteria (unclear) | Qingre huoxue qutan decoction (1 dose/d) + control | Captopril (12.5–25 mg bid) | 12 | BP |
Zheng (2012) [51] | 60 | CGMH-2010; PCGOOCA-2003; GCRNDTCM | Shugan yunpi decoction (600 mL/d) | Metformin (250 mg tid) | 8 | BP |
Liu (2006) [52] | 60 | 1979 WHO GMH; diagnostic criteria for obesity (unclear); TCM diagnostic criteria (unclear) | Taohong erchen tianma decoction (1 dose/d) + control | Captopril (12.5–25 mg bid) | 12 | BP |
He (2008) [53] | 65 | CGMH-2005; PCGOOCA-2003; GCRNDTCM | Decoction of activating blood and expelling phlegm (1 dose/d) + control | Perindopril (4 mg qd) | 3 | BP |
Chen and Xu (2008) [54] | 80 | CGMH-2005; PCGOOCA-2003; GCRNDTCM | Huanglian Wendan decoction (200 mL/d) + control | Amlodipine besylate (5 mg qd) | 4 | BP |
|